Your browser doesn't support javascript.
loading
Customization of a Model For Knowledge-Based Planning to Achieve Ideal Dose Distributions in Volume Modulated arc Therapy for Pancreatic Cancers.
Nitta, Yuya; Ueda, Yoshihiro; Isono, Masaru; Ohira, Shingo; Masaoka, Akira; Karino, Tsukasa; Inui, Shoki; Miyazaki, Masayoshi; Teshima, Teruki.
Afiliação
  • Nitta Y; Department of Radiation Oncology, Osaka International Cancer Institute, Osaka, Japan.
  • Ueda Y; Department of Radiation Oncology, Osaka International Cancer Institute, Osaka, Japan.
  • Isono M; Department of Radiation Oncology, Osaka International Cancer Institute, Osaka, Japan.
  • Ohira S; Department of Radiation Oncology, Osaka International Cancer Institute, Osaka, Japan.
  • Masaoka A; Department of Radiation Oncology, Osaka International Cancer Institute, Osaka, Japan.
  • Karino T; Department of Radiology, Osaka Women's and Children's Hospital, Osaka, Japan.
  • Inui S; Department of Radiation Oncology, Osaka International Cancer Institute, Osaka, Japan.
  • Miyazaki M; Department of Medical Physics and Engineering, Osaka University Graduate School, Osaka, Japan.
  • Teshima T; Department of Radiation Oncology, Osaka International Cancer Institute, Osaka, Japan.
J Med Phys ; 46(2): 66-72, 2021.
Article em En | MEDLINE | ID: mdl-34566285
ABSTRACT

PURPOSE:

To evaluate customizing a knowledge-based planning (KBP) model using dosimetric analysis for volumetric modulated arc therapy for pancreatic cancer. MATERIALS AND

METHODS:

The first model (M1) using 56 plans and the second model (M2) using 31 plans were created in the first 7 months of the study. The ratios of volume of both kidneys overlapping the expanded planning target volume to the total volume of both kidneys (Voverlap/Vwhole) were calculated in all cases to customize M1. Regression lines were derived from Voverlap/Vwhole and mean dose to both kidneys. The third model (M3) was created using 30 plans which data put them below the regression line. For validation, KBP was performed with the three models on 21 patients.

RESULTS:

V18 of the left kidney for M1 plans was 7.3% greater than for clinical plans. Dmean of the left kidney for M2 plans was 2.2% greater than for clinical plans. There was no significant difference between all kidney doses in M3 and clinical plans. Dmean of the left kidney for M2 plans was 2.2% greater than for clinical plans. Dmean to both kidneys did not differ significantly between the three models in validation plans with Voverlap/Vwhole lower than average. In plans with larger than average volumes, the Dmean of validation plans created by M3 was significantly lower for both kidneys by 1.7 and 0.9 Gy than with M1 and M2, respectively.

CONCLUSIONS:

Selecting plans to register in a model by analyzing dosimetry and geometry is an effective means of improving the KBP model.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Med Phys Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Med Phys Ano de publicação: 2021 Tipo de documento: Article